T. Hussain et al., BROMOCRIPTINE STIMULATES NA-ATPASE IN RENAL PROXIMAL TUBULES VIA THE CAMP PATHWAY(,K+), European journal of pharmacology, 321(2), 1997, pp. 259-263
The present study was undertaken to examine the effect of dopamine D-2
receptor activation on Na+,K+-ATPase activity in rat renal proximal t
ubule suspension. Bromocriptine, a dopamine D-2 receptor agonist, prod
uced a concentration (10(-9)-10(-5) M) dependent stimulation of Na+,K-ATPase activity which was antagonized by pretreating the tubules with
domperidone (1 mu M), a dopamine D-2 receptor antagonist. Forskolin (
1 mu M), a direct activator of adenylyl cyclase, inhibited Na+,K+-ATPa
se activity and reversed the stimulation of Na+,K+-ATPase activity ind
uced by bromocriptine. Pertussis toxin (200 ng/ml) treatment also abol
ished the bromocriptine-induced stimulation of Na+,K+-ATPase activity.
Bromocriptine attenuated forskolin-stimulated cAMP accumulation which
was blocked by pertussis toxin treatment of the tubules. The data sug
gest that dopamine D-2 receptor activation by bromocriptine leads to s
timulation of Na+,K+-ATPase activity which may be mediated through a p
ertussis-sensitive G protein and inhibition of adenylyl cyclase in rat
renal proximal tubules. (C) 1997 Elsevier Science B.V.